Answer
Apr 01, 2026 - 08:21 AM
Entresto is typically prescribed for patients with chronic heart failure with reduced ejection fraction (HFrEF), specifically in Stage C heart failure according to the ACC/AHA staging system. Stage C includes patients who have structural heart disease with prior or current symptoms of heart failure. Entresto helps reduce the risk of cardiovascular death and hospitalization in these patients.
